Smarter testing for better health.

Adaptive Sensory Technology (AST), a spinout from Harvard Medical School, is developing advanced, quantitative tools for detecting changes in functional vision. Their research began over a decade earlier as a lab project in basic vision science to improve how vision changes are detected in research experiments. AST's Quick Contrast Sensitivity Function (qCSF) method brings a new level of precision to vision assessment and has been applied to measure contrast sensitivity deficits in low vision, age-related macular degeneration, retinitis pigmentosa, glaucoma, multiple sclerosis, amblyopia, congenital and adult cataract, and Fabry's disease.

Their identity revolves around the geometric circle, suggesting both an eye and precision. The inherent adaptive nature of their technology is manifested in a dynamic identity that, like their technology, continuously evolves and is unique every time.